Global siRNA Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Description

The siRNA Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global siRNA Drugs market size will reach USD million in 2029, growing at a CAGR of % over the analysis period.

Market segmentation
siRNA Drugs market is split by Type and by Application. For the period 2023-2029, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Without GalNAc-conjugated
    With GalNAc-conjugated

Market segment by Application, can be divided into
    Genetic Disease
    Cancers
    Other

Market segment by players, this report covers
    Alnylam
    Novartis
    Sirnaomics
    Ribo Life Science

Market segment by regions, regional analysis covers
    North America
    Europe
    Asia-Pacific (China, Japan, South Korea, Rest of Asia-Pacific)
    South America
    Middle East & Africa

The content of the study subjects, includes a total of 8 chapters:
Chapter 1, to describe siRNA Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of siRNA Drugs, with recent developments and future plans
Chapter 3, the siRNA Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4, to break the market size data at the region level, with key companies in the key region and siRNA Drugs market forecast, by regions, with revenue, from 2023 to 2029.
Chapter 5 and 6, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2023 to 2029.
Chapter 7 and 8, to describe siRNA Drugs research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of siRNA Drugs
    1.2 Classification of siRNA Drugs by Type
        1.2.1 Overview: Global siRNA Drugs Market Size by Type: 2022 Versus 2028
        1.2.2 Global siRNA Drugs Revenue Market Share by Type in 2029
        1.2.3 Without GalNAc-conjugated
        1.2.4 With GalNAc-conjugated
    1.3 Global siRNA Drugs Market by Application
        1.3.1 Overview: Global siRNA Drugs Market Size by Application: 2023 Versus 2029
        1.3.2 Genetic Disease
        1.3.3 Cancers
        1.3.4 Other
    1.4 Global siRNA Drugs Market Size & Forecast
    1.5 Market Drivers, Restraints and Trends
        1.5.1 siRNA Drugs Market Drivers
        1.5.2 siRNA Drugs Market Restraints
        1.5.3 siRNA Drugs Trends Analysis

2 Company Profiles
    2.1 Alnylam
        2.1.1 Alnylam Details
        2.1.2 Alnylam Major Business
        2.1.3 Alnylam siRNA Drugs Product and Solutions
        2.1.4 Alnylam Recent Developments and Future Plans
    2.2 Novartis
        2.2.1 Novartis Details
        2.2.2 Novartis Major Business
        2.2.3 Novartis siRNA Drugs Product and Solutions
        2.2.4 Novartis Recent Developments and Future Plans
    2.3 Sirnaomics
        2.3.1 Sirnaomics Details
        2.3.2 Sirnaomics Major Business
        2.3.3 Sirnaomics siRNA Drugs Product and Solutions
        2.3.4 Sirnaomics Recent Developments and Future Plans
    2.4 Ribo Life Science
        2.4.1 Ribo Life Science Details
        2.4.2 Ribo Life Science Major Business
        2.4.3 Ribo Life Science siRNA Drugs Product and Solutions
        2.4.4 Ribo Life Science Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global siRNA Drugs Revenue and Share by Players (2023 & 2029)
    3.2 siRNA Drugs Players Head Office, Products and Services Provided
    3.3 siRNA Drugs Mergers & Acquisitions
    3.4 siRNA Drugs New Entrants and Expansion Plans

4 Global siRNA Drugs Forecast by Region
    4.1 Global siRNA Drugs Market Size by Region: 2023 VS 2029
    4.2 Global siRNA Drugs Market Size by Region, (2023-2029)
    4.3 North America
        4.3.1 Key Companies of siRNA Drugs in North America
        4.3.2 Current Situation and Forecast of siRNA Drugs in North America
        4.3.3 North America siRNA Drugs Market Size and Prospect (2023-2029)
    4.4 Europe
        4.4.1 Key Companies of siRNA Drugs in Europe
        4.4.2 Current Situation and Forecast of siRNA Drugs in Europe
        4.4.3 Europe siRNA Drugs Market Size and Prospect (2023-2029)
    4.5 Asia-Pacific
        4.5.1 Key Companies of siRNA Drugs in Asia-Pacific
        4.5.2 Current Situation and Forecast of siRNA Drugs in Asia-Pacific
        4.5.3 Asia-Pacific siRNA Drugs Market Size and Prospect (2023-2029)
        4.5.4 China
        4.5.5 Japan
        4.5.6 South Korea
    4.6 South America
        4.6.1 Key Companies of siRNA Drugs in South America
        4.6.2 Current Situation and Forecast of siRNA Drugs in South America
        4.6.3 South America siRNA Drugs Market Size and Prospect (2023-2029)
    4.7 Middle East & Africa
        4.7.1 Key Companies of siRNA Drugs in Middle East & Africa
        4.7.2 Current Situation and Forecast of siRNA Drugs in Middle East & Africa
        4.7.3 Middle East & Africa siRNA Drugs Market Size and Prospect (2023-2029)

5 Market Size Segment by Type
    5.1 Global siRNA Drugs Market Forecast by Type (2023-2029)
    5.2 Global siRNA Drugs Market Share Forecast by Type (2023-2029)

6 Market Size Segment by Application
    6.1 Global siRNA Drugs Market Forecast by Application (2023-2029)
    6.2 Global siRNA Drugs Market Share Forecast by Application (2023-2029)

7 Research Findings and Conclusion

8 Appendix
    8.1 Methodology
    8.2 Research Process and Data Source
    8.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global siRNA Drugs Revenue by Type, (USD Million), 2023 VS 2029
    Table 2. Global siRNA Drugs Revenue by Application, (USD Million), 2023 VS 2029
    Table 3. Alnylam Corporate Information, Head Office, and Major Competitors
    Table 4. Alnylam Major Business
    Table 5. Alnylam siRNA Drugs Product and Solutions
    Table 6. Novartis Corporate Information, Head Office, and Major Competitors
    Table 7. Novartis Major Business
    Table 8. Novartis siRNA Drugs Product and Solutions
    Table 9. Sirnaomics Corporate Information, Head Office, and Major Competitors
    Table 10. Sirnaomics Major Business
    Table 11. Sirnaomics siRNA Drugs Product and Solutions
    Table 12. Ribo Life Science Corporate Information, Head Office, and Major Competitors
    Table 13. Ribo Life Science Major Business
    Table 14. Ribo Life Science siRNA Drugs Product and Solutions
    Table 15. Global siRNA Drugs Revenue (USD Million) by Players (2023 & 2029)
    Table 16. Global siRNA Drugs Revenue Share by Players (2023 & 2029)
    Table 17. siRNA Drugs Players Head Office, Products and Services Provided
    Table 18. siRNA Drugs Mergers & Acquisitions in the Past Five Years
    Table 19. siRNA Drugs New Entrants and Expansion Plans
    Table 20. Global Market siRNA Drugs Revenue (USD Million) Comparison by Region (2023 VS 2029)
    Table 21. Global siRNA Drugs Revenue Market Share by Region (2023-2029)
    Table 22. Key Companies of siRNA Drugs in North America
    Table 23. Current Situation and Forecast of siRNA Drugs in North America
    Table 24. Key Companies of siRNA Drugs in Europe
    Table 25. Current Situation and Forecast of siRNA Drugs in Europe
    Table 26. Key Companies of siRNA Drugs in Asia-Pacific
    Table 27. Current Situation and Forecast of siRNA Drugs in Asia-Pacific
    Table 28. Key Companies of siRNA Drugs in China
    Table 29. Key Companies of siRNA Drugs in Japan
    Table 30. Key Companies of siRNA Drugs in South Korea
    Table 31. Key Companies of siRNA Drugs in South America
    Table 32. Current Situation and Forecast of siRNA Drugs in South America
    Table 33. Key Companies of siRNA Drugs in Middle East & Africa
    Table 34. Current Situation and Forecast of siRNA Drugs in Middle East & Africa
    Table 35. Global siRNA Drugs Revenue Forecast by Type (2023-2029)
    Table 36. Global siRNA Drugs Revenue Forecast by Application (2023-2029)
List of Figures
    Figure 1. siRNA Drugs Picture
    Figure 2. Global siRNA Drugs Revenue Market Share by Type in 2029
    Figure 3. Without GalNAc-conjugated
    Figure 4. With GalNAc-conjugated
    Figure 5. siRNA Drugs Revenue Market Share by Application in 2029
    Figure 6. Genetic Disease Picture
    Figure 7. Cancers Picture
    Figure 8. Other Picture
    Figure 9. Global siRNA Drugs Market Size, (USD Million): 2023 VS 2029
    Figure 10. Global siRNA Drugs Revenue and Forecast (2023-2029) & (USD Million)
    Figure 11. siRNA Drugs Market Drivers
    Figure 12. siRNA Drugs Market Restraints
    Figure 13. siRNA Drugs Market Trends
    Figure 14. Alnylam Recent Developments and Future Plans
    Figure 15. Novartis Recent Developments and Future Plans
    Figure 16. Sirnaomics Recent Developments and Future Plans
    Figure 17. Ribo Life Science Recent Developments and Future Plans
    Figure 18. Global siRNA Drugs Revenue Market Share by Region (2023-2029)
    Figure 19. Global siRNA Drugs Revenue Market Share by Region in 2029
    Figure 20. North America siRNA Drugs Revenue (USD Million) and Growth Rate (2023-2029)
    Figure 21. Europe siRNA Drugs Revenue (USD Million) and Growth Rate (2023-2029)
    Figure 22. Asia-Pacific siRNA Drugs Revenue (USD Million) and Growth Rate (2023-2029)
    Figure 23. South America siRNA Drugs Revenue (USD Million) and Growth Rate (2023-2029)
    Figure 24. Middle East & Africa siRNA Drugs Revenue (USD Million) and Growth Rate (2023-2029)
    Figure 25. Global siRNA Drugs Market Share Forecast by Type (2023-2029)
    Figure 26. Global siRNA Drugs Market Share Forecast by Application (2023-2029)
    Figure 27. Methodology
    Figure 28. Research Process and Data Source